{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T01:02:18Z","timestamp":1779930138478,"version":"3.53.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:00:00Z","timestamp":1593129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pepsin agglutinators, discovered over 50\u2009years ago, have been recently referred to as anti-hinge antibodies (AHAs) because of their reaction with the IgG hinge epitope. AHAs have different reactivity for each hinge epitope generated by each protease that cleaves the hinge region at different sites. Moreover, AHAs have different reactivity against different hinge epitopes derived from each IgG subclass even when the same protease is used. Since the expression of matrix metalloproteinase-3 (MMP-3) is enhanced in rheumatoid arthritis (RA), AHA production could also be increased. The purpose of this study was to determine whether the levels of AHAs against IgG hinge epitopes produced by MMP-3 are elevated in RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The serum levels of IgG or IgA AHAs against the IgG1\/IgG4 F(ab\u2019)\n                      <jats:sub>2<\/jats:sub>\n                      fragments, generated by either MMP-3 or pepsin, were measured using ELISA in 111 patients with RA and 81 healthy controls (HC). Receiver operating characteristic (ROC) analysis was used for obtaining optimal cutoff values and cutoff values indicating high specificity (&gt;\u200995%) of the AHA. The targeted epitope of a specific AHA was investigated through inhibition ELISA.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seven AHAs were statistically higher in RA patients than in HC, except IgG AHA against IgG1 F(ab\u2019)\n                      <jats:sub>2<\/jats:sub>\n                      , which was generated by MMP-3 proteolytic cleavage. The areas under the ROC curve were 0.66\u20130.80, although the sensitivities at high specificity were low (5.4\u201324.3%). The cumulative number of positive AHAs in each individual was statistically higher in RA patients than in HC, suggesting the extreme extent of AHA repertoires in RA. Inhibition studies revealed that IgG AHAs against IgG4 F(ab\u2019)\n                      <jats:sub>2<\/jats:sub>\n                      fragments generated by pepsin cross-reacted with IgG1 F(ab\u2019)\n                      <jats:sub>2<\/jats:sub>\n                      fragments generated by pepsin. Multivariate logistic regression analysis identified the IgG AHA against IgG4 F(ab\u2019)\n                      <jats:sub>2<\/jats:sub>\n                      fragments generated by pepsin as an independent variable for RA diagnosis, even in RA patients who were negative for both RF and ACPA (odds ratio 1.18, 95% CI 1.06\u20131.32;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003). Additional experiments using non-RA patients finally strengthened the diagnostic utility.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      In RA patients, we observed diversification and amplification of AHA repertoires and diagnostic utility of the specific AHA against IgG4 F(ab\u2019)\n                      <jats:sub>2<\/jats:sub>\n                      fragments generated by pepsin but not MMP-3.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-020-02251-7","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T00:37:20Z","timestamp":1593131840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["IgG anti-hinge antibodies against IgG4 F(ab\u2019)2 fragments generated using pepsin are useful diagnostic markers for rheumatoid arthritis: implications of the possible roles of metalloproteinases and IgG subclasses in generating immunogenic hinge epitopes"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-0137","authenticated-orcid":false,"given":"Toshiyuki","family":"Ota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-ichiro","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Nagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"2251_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023\u201338.","journal-title":"Lancet."},{"key":"2251_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrrheum.2017.15","volume":"13","author":"LA Trouw","year":"2017","unstructured":"Trouw LA, Rispens T, Toes REM. Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis. Nat Rev Rheumatol. 2017;13:331\u20139.","journal-title":"Nat Rev Rheumatol"},{"key":"2251_CR3","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/j.molimm.2007.10.043","volume":"45","author":"MH Ryan","year":"2008","unstructured":"Ryan MH, Petrone D, Nemeth JF, Barnathan E, Bjorck L, Jordan RE. Proteolysis of purified IgGs by human and bacterial enzymes in vitro and the detection of specific proteolytic fragments of endogenous IgG in rheumatoid synovial fluid. Mol Immunol. 2008;45:1837\u201346.","journal-title":"Mol Immunol"},{"key":"2251_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.4161\/mabs.2.3.11780","volume":"2","author":"RJ Brezski","year":"2010","unstructured":"Brezski RJ, Jordan RE. Cleavage of IgGs by proteases associated with invasive diseases: an evasion tactic against host immunity? MAbs. 2010;2:212\u201320.","journal-title":"MAbs."},{"key":"2251_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1159\/000460705","volume":"8","author":"CK Osterland","year":"1963","unstructured":"Osterland CK, Harboe M, Kunkel HG. Anti-gamma-globulin factors in human sera revealed by enzymatic splitting of anti-Rh antibodies. Vox Sang. 1963;8:133\u201352.","journal-title":"Vox Sang"},{"key":"2251_CR6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1002\/art.1780251105","volume":"25","author":"R Heimer","year":"1982","unstructured":"Heimer R, Wolfe LD, Abruzzo JL. IgM and IgG anti-F (ab\u2019)2 antibodies in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1982;25:1298\u2013306.","journal-title":"Arthritis Rheum"},{"key":"2251_CR7","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1100\/tsw.2011.107","volume":"11","author":"RJ Brezski","year":"2011","unstructured":"Brezski RJ, Knight DM, Jordan RE. The origins, specificity, and potential biological relevance of human anti-IgG hinge autoantibodies. ScientificWorldJournal. 2011;11:1153\u201367.","journal-title":"ScientificWorldJournal."},{"key":"2251_CR8","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S0198-8859(98)00132-3","volume":"60","author":"M Welschof","year":"1999","unstructured":"Welschof M, Reineke U, Kleist C, Kipriyanov S, Little M, Volkmer-Engert R, et al. The antigen binding domain of non-idiotypic human anti-F (ab\u2019)2 autoantibodies: study of their interaction with IgG hinge region epitopes. Hum Immunol. 1999;60:282\u201390.","journal-title":"Hum Immunol"},{"key":"2251_CR9","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.4049\/jimmunol.181.5.3183","volume":"181","author":"RJ Brezski","year":"2008","unstructured":"Brezski RJ, Luongo JL, Petrone D, Ryan MH, Zhong D, Tam SH, et al. Human anti-IgG1 hinge autoantibodies reconstitute the effector functions of proteolytically inactivated IgGs. J Immunol. 2008;181:3183\u201392.","journal-title":"J Immunol"},{"key":"2251_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.4049\/jimmunol.1601096","volume":"198","author":"WJ Falkenburg","year":"2017","unstructured":"Falkenburg WJ, van Schaardenburg D, Ooijevaar-de Heer P, Tsang-A-Sjoe MWP, Bultink IEM, Voskuyl AE, et al. Anti-hinge antibodies recognize IgG subclass- and protease-restricted neoepitopes. J Immunol. 2017;198:82\u201393.","journal-title":"J Immunol"},{"key":"2251_CR11","first-page":"888","volume":"27","author":"C Ribbens","year":"2000","unstructured":"Ribbens C, Andre B, Jaspar JM, Kaye O, Kaiser MJ, De Groote D, et al. Matrix metalloproteinase-3 serum levels are correlated with disease activity and predict clinical response in rheumatoid arthritis. J Rheumatol. 2000;27:888\u201393.","journal-title":"J Rheumatol"},{"key":"2251_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/ard.59.6.455","volume":"59","author":"Y Yoshihara","year":"2000","unstructured":"Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis. 2000;59:455\u201361.","journal-title":"Ann Rheum Dis"},{"key":"2251_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0165-2478(01)00333-9","volume":"81","author":"AJ Gearing","year":"2002","unstructured":"Gearing AJ, Thorpe SJ, Miller K, Mangan M, Varley PG, Dudgeon T, et al. Selective cleavage of human IgG by the matrix metalloproteinases, matrilysin and stromelysin. Immunol Lett. 2002;81:41\u20138.","journal-title":"Immunol Lett"},{"key":"2251_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"Pt 1","key":"2251_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1042\/bj2760217","volume":"276","author":"PA Koklitis","year":"1991","unstructured":"Koklitis PA, Murphy G, Sutton C, Angal S. Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities. Biochem J. 1991;276(Pt 1):217\u201321.","journal-title":"Biochem J"},{"key":"2251_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1084\/jem.121.4.503","volume":"121","author":"M Harboe","year":"1965","unstructured":"Harboe M, Rau B, Aho K. Properties of various anti-gamma-globulin factors in human sera. J Exp Med. 1965;121:503\u201319.","journal-title":"J Exp Med"},{"issue":"1","key":"2251_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/0090-1229(82)90167-2","volume":"25","author":"H Nasu","year":"1982","unstructured":"Nasu H, Chia DS, Taniguchi O, Barnett EV. Characterization of anti-F (ab\u2019)2 antibodies in SLE patients. Evidence for cross-reacting auto-anti-idiotypic antibodies. Clin Immunol Immunopathol. 1982;25(1):80\u201390.","journal-title":"Clin Immunol Immunopathol"},{"key":"2251_CR18","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.4049\/jimmunol.154.12.6446","volume":"154","author":"P Terness","year":"1995","unstructured":"Terness P, Kohl I, Hubener G, Battistutta R, Moroder L, Welschof M, et al. The natural human IgG anti-F (ab\u2019)2 antibody recognizes a conformational IgG1 hinge epitope. J Immunol. 1995;154:6446\u201352.","journal-title":"J Immunol"},{"key":"2251_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000233031","volume":"67","author":"MP Davey","year":"1982","unstructured":"Davey MP, Korngold L. Association of anti-F (ab\u2019)2 antibodies (pepsin agglutinators) with immune complexes as determined by enzyme-linked immunosorbent assays. Int Arch Allergy Appl Immunol. 1982;67:278\u201383.","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"2251_CR20","doi-asserted-by":"crossref","unstructured":"Terness P, Kirschfink M, Navolan D, Dufter C, Kohl I, Opelz G, et al. Striking inverse correlation between IgG anti-F (ab\u2019)2 and autoantibody production in patients with cold agglutination. Blood. 1995;85:548\u201351.","DOI":"10.1182\/blood.V85.2.548.bloodjournal852548"},{"key":"2251_CR21","first-page":"451","volume":"8","author":"M Waller","year":"1971","unstructured":"Waller M, Duma RJ, Farley ED Jr, Atkinson J. The influence of infection on titres of antiglobulin antibodies. Clin Exp Immunol. 1971;8:451\u20139.","journal-title":"Clin Exp Immunol"},{"key":"2251_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ijc.2910570109","volume":"57","author":"C Susal","year":"1994","unstructured":"Susal C, Maier H, Lorenz K, Opelz G. Association of IgA-anti-Fab autoantibodies with disease stage in head-and-neck cancer. Int J Cancer. 1994;57:47\u201350.","journal-title":"Int J Cancer"},{"key":"2251_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1423-0410.1994.tb00274.x","volume":"66","author":"C Susal","year":"1994","unstructured":"Susal C, Oberg HH, Daniel V, Dorr C, Terness P, Huth-Kuhne A, et al. Isotypes and IgG subclasses of anti-Fab antibodies in human immunodeficiency virus-infected hemophilia patients. Vox Sang. 1994;66:37\u201345.","journal-title":"Vox Sang"},{"key":"2251_CR24","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1172\/JCI112027","volume":"76","author":"JE Persselin","year":"1985","unstructured":"Persselin JE, Stevens RH. Anti-Fab antibodies in humans. Predominance of minor immunoglobulin G subclasses in rheumatoid arthritis. J Clin Invest. 1985;76:723\u201330.","journal-title":"J Clin Invest"},{"key":"2251_CR25","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1038\/emm.2017.24","volume":"49","author":"D Kim","year":"2017","unstructured":"Kim D, Zeng MY, Nunez G. The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Exp Mol Med. 2017;49:e339.","journal-title":"Exp Mol Med"},{"key":"2251_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","volume":"14","author":"VM Holers","year":"2018","unstructured":"Holers VM, Demoruelle MK, Kuhn KA, Buckner JH, Robinson WH, Okamoto Y, et al. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat Rev Rheumatol. 2018;14:542\u201357.","journal-title":"Nat Rev Rheumatol"},{"key":"2251_CR27","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/art.10263","volume":"46","author":"F Monneaux","year":"2002","unstructured":"Monneaux F, Muller S. Epitope spreading in systemic lupus erythematosus: identification of triggering peptide sequences. Arthritis Rheum. 2002;46:1430\u20138.","journal-title":"Arthritis Rheum"},{"key":"2251_CR28","doi-asserted-by":"publisher","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","volume":"7","author":"J Sokolove","year":"2012","unstructured":"Sokolove J, Bromberg R, Deane KD, Lahey LJ, Derber LA, Chandra PE, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One. 2012;7:e35296.","journal-title":"PLoS One"},{"key":"2251_CR29","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/art.37835","volume":"65","author":"M Brink","year":"2013","unstructured":"Brink M, Hansson M, Mathsson L, Jakobsson PJ, Holmdahl R, Hallmans G, et al. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum. 2013;65:899\u2013910.","journal-title":"Arthritis Rheum"},{"key":"2251_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrrheum.2011.204","volume":"8","author":"A Willemze","year":"2012","unstructured":"Willemze A, Trouw LA, Toes RE, Huizinga TW. The influence of ACPA status and characteristics on the course of RA. Nat Rev Rheumatol. 2012;8:144\u201352.","journal-title":"Nat Rev Rheumatol"},{"key":"2251_CR31","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.1002\/art.23763","volume":"58","author":"A Ioan-Facsinay","year":"2008","unstructured":"Ioan-Facsinay A, Willemze A, Robinson DB, Peschken CA, Markland J, van der Woude D, et al. Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease. Arthritis Rheum. 2008;58:3000\u20138.","journal-title":"Arthritis Rheum"},{"key":"2251_CR32","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/ar2903","volume":"12","author":"GJ Pruijn","year":"2010","unstructured":"Pruijn GJ, Wiik A, van Venrooij WJ. The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis. Arthritis Res Ther. 2010;12:203.","journal-title":"Arthritis Res Ther"},{"key":"2251_CR33","doi-asserted-by":"publisher","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","volume":"146","author":"K Nishimura","year":"2007","unstructured":"Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Inten Med. 2007;146:797\u2013808.","journal-title":"Ann Inten Med"},{"key":"2251_CR34","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","volume":"191","author":"TJ Doyle","year":"2015","unstructured":"Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, et al. Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers. Am J Respir Crit Care Med. 2015;191:1403\u201312.","journal-title":"Am J Respir Crit Care Med"},{"key":"2251_CR35","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/gene.2012.65","volume":"14","author":"MG Kazantseva","year":"2013","unstructured":"Kazantseva MG, Hung NA, Highton J, Hessian PA. MMP expression in rheumatoid inflammation: the rs11568818 polymorphism is associated with MMP-7 expression at an extra-articular site. Genes Immun. 2013;14:162\u20139.","journal-title":"Genes Immun"},{"key":"2251_CR36","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1002\/art.22279","volume":"54","author":"KN Verpoort","year":"2006","unstructured":"Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort EA, Ioan-Facsinay A, Drijfhout JW, van Tol MJ, et al. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum. 2006;54:3799\u2013808.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02251-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02251-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T19:24:52Z","timestamp":1696274692000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02251-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2251"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02251-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21747\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21747\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21747\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21747\/v3","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,26]]},"assertion":[{"value":"20 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Ethics Committee at the Iizuka Hospital, Iizuka, Japan, approved this study (reference number: 26143), and participants gave informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}